Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(30 sites)
China
Xuancheng People's Hospital, Xuancheng, Anhui Beijing Chaoyang Hospital, Beijing, Beijing Municipality The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Shenzhen Eye Hospital, Shenzhen, Guangdong Zhuhai People's Hospital, Zhuhai, Guangdong The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou Guizhou Provincial People's Hospital, Guiyang, Guizhou Shijiazhuang People's Hospital, Shijiazhuang, Hebei Kaifeng Central Hospital, Kaifeng, Henan Luoyang Third People's Hospital, Luoyang, Henan Xinxiang Central Hospital, Xinxiang, Henan People's Hospital of Zhengzhou, Zhengzhou, Henan Zhengzhou Second Hospital, Zhengzhou, Henan Taihe Hospital （Affiliated Hospital Of Hubei University Of Medicine）, Shiyan, Hubei Wuhan Puren Hospital, Wuhan, Hubei Yichang Central People's Hospital, Yichang, Hubei The First Affiliated Hospital Of University Of South China, Hengyang, Hunan Wuxi People's Hospital, Wuxi, Jiangsu Affiliated Zhongshan Hospital Dalian University, Dalian, Liaoning Shandong University of Traditional Chinese Medicine Affiliated Eye Hospital, Jinan, Shandong Shandong University of Traditional Chinese Medicine Affiliated Hospital, Jinan, Shandong Shandong Provincial Hospital, Jinan, Shandong Shandong Second Provincial General Hospital, Jinan, Shandong Liaocheng People's Hospital, Liaocheng, Shandong The First People'S Hospitalof Xian Yang, Xianyang, Shanxi Xian No.1 Hospital, Xi’an, Shanxi The First Affiliated Hospital of Xi'an Medical University, Xi’an, Shanxi The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuang Panzhihua Integrated Traditional Chinese and Western Medicine Hospital, Panzhihua, Sichuang Yunnan University Affiliated Hospital, Kunming, Yunnan